谈现代生物技术改写传统食品发酵工艺的历史

人类对生命科学研究的持续开展极大地促进了农业生物技术和工业生物技术的发展,引发了人类健康事业的历史性变革。现代化生物技术的突飞猛进,改写了食品发酵工艺的历史。展望现代生物技术领域的发展趋势,把握世界现代生物技术领域的发展态势,对大力提高我国科技自主创新能力具有极其重要的意义。     

谈现代生物技术改写传统食品发酵工艺的历史

人类对生命科学研究的持续开展极大地促进了农业生物技术和工业生物技术的发展,引发了人类健康事业的历史性变革。现代化生物技术的突飞猛进,改写了食品发酵工艺的历史。展望现代生物技术领域的发展趋势,把握世界现代生物技术领域的发展态势,对大力提高我国科技自主创新能力具有极其重要的意义。     

生物产业生机无限

2010年10月18日发布的《国务院关于加快培育和发展战略性新兴产业的决定》规划到2020年生物产业将成为中国国民经济的支柱产业。发改委随后在对有关决定解读时指出,生命科学和生物技术将是从根本上影响21世纪人类发展的重大领域,将对改变消耗自然资源的传统发展模式、构建绿色可再生产业体系、促进人类健康产生革命性影响。我国在生命科学和生物技术领域具有坚实的基础,具有发展的巨大市场空间,生物产业未来发     

现代生物技术在水污染控制中的应用

当今的水处理技术中,生物处理法已成为水污染控制的主要方法,尤其是现代生物技术将成为水污染控制领域重点开发和应用的技术手段。本文介绍了现代生物技术的内容与特点,着重综述了现代生物技术在废水生物处理、生物修复以及微生物水处理剂等方面的研究与应用状况,在此基础上提出今后现代生物技术在水污染控制领域中的研究方向。     

浅析现代生物技术在水污染控制中的应用

当今的水处理技术中生物处理法已成为水污染控制的主要方法,尤其是现代生物技术将成为水污染控制领域重点开发和应用的技术手段。本文介绍了现代生物技术的内容与特点,着重综述了现代生物技术在废水生物处理、生物修复以及微生物水处理剂等方面的研究与应用状况,在此基础上提出今后现代生物技术在水污染控制领域中的研究方向。     

生物技术与农业发展

农业是人类社会生产的一个重要组成部分,是生物技术开发的重要领域和要攻克的主要目标之一。21世纪将是生物学的世纪,那时生物技术产生的影响将会波及人类社会的各个领域。当前要缓和农业、人口、能源、资源和环境等人类面临的危机,在很大程度上有赖于生物技术。因此,我们有必要对这项技术主要的应用领域——农业领域做一些简单的了解,为即将到来的生物技术时代做好准备。     

"生物技术"您知道吗?

编者的话:随着现代生物技术的迅速发展和广泛应用,已影响人类生活方方面面发生深刻变化.为了帮助读者了解有关生物技术知识,在发展乡镇企业中尽快涉足这一高科技技术,本期特编发了以下两篇文章,供大家学习参考.     

发展海洋生物高新技术 促进海洋知识经济发展

随着科学技术的突飞猛进,知识经济已现端倪。知识与技术的创新将成为未来社会文化的基础与核心。海洋生物技术是运用现代生物学、化学和工程学的手段,利用海洋生物体、生命系统和生命过程,生产有用产品的一门高技术科学,是现代生物技术与海洋生物学相交叉的产物,是80年代以来发展起来的新兴科学技术领域。‘已将使人类更有效地开发海洋生物资源,从海洋中获得更多的食品、蛋白、营养品、治疗疑难病的特效药物和特殊功能的生化产品等,对人多地少的我国生存和发展具有重要意义,将是未来知识经济的重要体现。继医药生物技术,农业生物技…     

浅谈制药新技术的应用

20世纪70年代,现代生物技术呈迅猛发展之势,同时它作为一项高科技,与医药产业密切结合,推动某些医学基础学科实现了革命性的发展,进而开拓了医药工业新领域,为人类的健康造福。     

蓬勃发展的德州市生物技术产业

<正>生物技术产业作为二十一世纪的新兴产业、朝阳产业,其广阔的应用前景、巨大的市场潜力、日新月异的技术进步,正为所有进入者提供着良好的发展机遇。生物技术将为人类社会发展提供新资源、新手段、新途径,并引发医药、农业、能源、材料等领域     

浅谈我省建立生物医药产业基地对于价值链延伸和产业化升级的意义

21世纪是生命科学的时代,生物技术的作用和潜力日益显现,以生物技术为支撑的生物产业,正在成为一个新的最具活力的经济增长点。未来谁拥有生物技术创新优势,谁就能占据生物产业竞争的制高点,掌握未来经济竞争的主动权。河北省生物医药产业基地的建设对于我省的生物产业发展是有重要意义的,本文就对此进行了分析研究。     

The relevance of pecking order hypothesis for the financing of computer software and biotechnology small firms: some UK evidence

This study explores the funding issues at the early stages of development of computer software and biotechnology small firms in the UK. This study reviewed previous relevant literature in this area and presents empirical evidence derived from an extensive online questionnaire survey. The sample contains a total of 83 small firms, which includes 41 biotechnology and 42 software firms. With regards to funding issues, we found that software firms reports more funding problems than the biotechnology firms. Software firms are fastest growing firms and goes through the early stages of development quicker than the biotechnology firms. With regards to the sources of funding the evidence shows that biotechnology small firms mainly use venture capital finance whilst the main source of funding for the software firms are personal savings and house mortgage/re-mortgage. On the one hand, software firms seem to follow the pecking order hypothesis whilst financing their business growth and development. On the other hand, the pecking order hypothesis may not be fully followed by the biotechnology small firms. However, both software and biotechnology small firms report difficulties in securing equity finance. Software firms are financially constrained not only due to the supply side financial constraints but also by the demand side financial constraints.     

高素质应用型生物学人才的培养模式探析

新世纪高素质应用型生物学人才的培养主要通过生物技术专业的人才培养来实现。该文比较了我国生物技术专业的人才培养目标、培养方案和培养模式,分析了生物技术专业产学研结合情况,发现现状不容乐观,由于涉及技术保密、车间GMP管理等问题,学生并不能真正参与生产过程。最后对生物技术专业办学提出了5点建议,并重点建议生物技术专业办学应该建设一个模拟生物技术领域大部分制造、研发工艺的实训平台。     

Is technology integration the solution to biotechnology's low research and development productivity?

The demand for innovative and cost-effective products has had considerable impact on the Research and Development (R&D) portfolio of pharmaceutical companies. With the advent of the new enabling technologies, the biotechnology revolution has created a need for a new and more appropriate paradigm for drug development. The progress in the biological understanding of disease processes and related technological developments have been a major step forward for drug discovery. However, the great majority of the biotechnology companies are confronted with the same issues as major pharmaceutical companies in terms of R&D productivity. This article intends to unfold the challenges faced by biotechnology companies involved in drug discovery by managing the complexity, uncertainty and urgency of technology integration through organic, acquisition and partnering strategies have become priorities for biotechnology companies in helping them achieving more efficiency in their pharmaceutical R&D efforts. Such strategies help biotechnology companies apply their technologies across a broad range of applications within the drug discovery value chain to maximize opportunities for product development. Competitive advantage in the marketplace ultimately derives from providing better speed, cost, quality and direction.     

现代生物技术在食品领域中的应用研究

现代生物学和分子生物学的发展,对基因工程、细胞工程、酶工程、发酵工程等现代生物技术工程产生重要影响,其在食品发酵生产中的应用越来越广。本文阐述了基因工程、细胞工程、酶工程等现代生物技术在食品发酵业的应用。     

On the dynamics of national scientific systems

Coauthorship links actors at the micro-level of scientists. Through electronic databases we now have enough information to compare entire research disciplines over time. We compare the complete longitudinal coauthorship networks for four research disciplines (biotechnology, mathematics, physics and sociology) for 1986–2005. We examined complete bibliographies of all researchers registered at the national Slovene Research Agency. Known hypotheses were confirmed as were three new hypotheses. There were different coauthoring cultures. However, these cultures changed over time in Slovenia. The number of coauthored publications grew much faster than solo authored productions, especially after independence in 1991 and the integration of Slovenian science into broader EU systems. Trajectories of types of coauthorship differed across the disciplines. Using blockmodeling, we show how coauthorship structures change in all disciplines. The most frequent form was a core-periphery structure with multiple simple cores, a periphery and a semi-periphery. The next most frequent form had this structure but with bridging cores. Bridging cores consolidate the center of a discipline by giving it greater coherence. These consolidated structures appeared at different times in different disciplines, appearing earliest in physics and latest in biotechnology. In 2005, biotechnology had the most consolidated center followed by physics and sociology. All coauthorship networks expanded over time. By far, new recruits went into either the semi-periphery or the periphery in all fields. Two ‘lab’ fields, biotechnology and physics, have larger semi-peripheries than peripheries. The reverse holds for mathematics and sociology, two ‘office’ disciplines. Institutional affiliations and shared interests all impact the structure of collaboration in subtle ways.     

Emerging Australian Biotechnology Companies: Globalizing or Just Playing?

The biotechnology industry is seen as one of the most globalized. It is also an industry dominated by SMEs in most countries. It would be expected then that these biotechnology SMEs themselves would be global in their focus. It is the intent of this research to understand the globalization issues that are encouraging biotechnology companies to go global, whether these companies really are truly global companies, and if not, at which stage of the globalization process these companies are operating. The study is undertaken using secondary quantitative data on all the publicly listed biotechnology companies in Australia that have undertaken some form of internationalization, based on 2003/4 annual reports. The main conclusion from the research is Australian biotechnology companies are still in an immature stage of development in the globalization process. The companies’ market strategies are directed at profitable countries and regions, such as the USA and Europe. This neglects other markets that are more accessible and can provide much needed early income streams. The internationalization effort of Australian biotechnology companies is only partial and could not be considered to be a true globalization effort.     

高职生物技术及应用专业顶岗实习现状、存在问题、影响因素及其对策分析

本文以南通职业大学生物技术及应用专业为例,分析了高职生物技术及应用专业顶岗实习现状、存在问题及其影响因素,并从政府、学校、企业、学生四个层面初步提出了提高高职生物技术及应用专业顶岗实习质量的对策。     

Closing the innovative loop: moving from the laboratory to the shop floor in biotechnology manufacturing

Innovation is a hallmark of successful technology-intensive start-up companies. This paper considers manufacturing as a knowledge-generating activity integral to product innovation in entrepreneurial biotechnology firms. The model of the virtual corporation has been advocated as a means to focus on the resources of start-up companies; yet regional specialization in technical applications and product categories suggests that manufacturing may be a knowledge-generating activity that can provide a potential source of regional advantage. This paper considers the manufacturing strategies that bio-entrepreneurs would like to pursue and explores barriers to forward integration. While capital constraints may force firms to licence and subcontract manufacturing, it was found that entrepreneurs believe that it is important to undertake manufacturing and, when they are financially able, they invest in manufacturing facilities. The authors conclude by providing a framework for considering when it might be most appropriate for biotechnology firms to invest in manufacturing.